Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 5/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 6/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CASP1 | P29466 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23081351 | 0.96 | CYP1A2 (0.43) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL14262642 | 0.87 | CYP1A2 (0.37) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL12683584 | 0.86 | CYP1A2 (0.36) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL503375 | 0.86 | CYP1A2 (0.44) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL1061284 | 0.86 | ALDH1A1 (0.48) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL25630679 | 0.84 | ESR1 (0.35) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL5413836 | 0.84 | ALDH1A1 (0.52) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL14262644 | 0.83 | CYP1A2 (0.33) | ALDH1A1HPGDCYP1A2HSD17B10THRB | |
| SCHEMBL15373022 | 0.82 | CYP1A2 (0.38) | ALDH1A1HPGDCYP1A2HSD17B10ACHE | |
| SCHEMBL28753940 | 0.81 | ALDH1A1 (0.54) | ALDH1A1HPGDCYP1A2HSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9472766-B2 | Fused polycyclic compound and organic light emitting element including the same | CANON KABUSHIKI KAISHA (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20080074045-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-1138745-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1757670-A2 | Organic electroluminescent element | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-20070003788-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060024523-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2006-02-02 | — | — | US | disclosed |
| US-6818327-B2 | COLOR PURITY, EFFICIENCY | IDEMITSU KOSAN CO., LTD. (JP) | 2004-11-16 | — | — | US | disclosed |
| US-6815090-B1 | ACENAPTHO(1,2-K)FLUORANTHENE DERIVATIVES; COLOR PURITY, EFFICIENT LIGHT EMISSION, DURABILITY | IDEMITSU KOSAN CO., LTD. (JP) | 2004-11-09 | — | — | US | disclosed |
| US-20040214043-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2004-10-28 | — | — | US | disclosed |
| US-20030054200-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-1138745-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160035982-A1 | NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME | NR2E3, PUF60, CRY2 | ALDH1A1 897/4885HPGD 3473/4885CYP1A2 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.